Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
32.02
+0.36 (1.14%)
At close: Sep 30, 2026, 4:00 PM EDT
33.00
+0.98 (3.06%)
After-hours: Sep 30, 2026, 7:58 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.56 billion as of September 30, 2026. Its market cap has increased by 181.40% in one year.
Market Cap
5.56B
Enterprise Value
5.01B
1-Year Change
181.40%
Ranking
Category
Stock Price
$32.02
ChartMarket Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.56B, an increase of 4,372.22%. That is a compound annual growth rate of 84.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 5.56B | 2.85% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 6.17B |
| Scholar Rock Holding | 5.98B |
| Travere Therapeutics | 5.80B |
| Mirum Pharmaceuticals | 5.71B |
| Kodiak Sciences | 5.64B |
| Oruka Therapeutics | 5.57B |
| PTC Therapeutics | 5.50B |
| CRISPR Therapeutics AG | 5.23B |